For: | Sun QH, Wang HY, Sun SD, Zhang X, Zhang H. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial. World J Gastroenterol 2019; 25(17): 2110-2121 [PMID: 31114137 DOI: 10.3748/wjg.v25.i17.2110] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i17/2110.htm |
Number | Citing Articles |
1 |
Yuzhe Fei, Ruiru Wang, Jiachun Lu, Songhao Peng, Song Yang, Yiting Wang, Kaixuan Zheng, Ran Li, Lin Lin, Maoquan Li. Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment. Geriatric Nursing 2023; 51: 167 doi: 10.1016/j.gerinurse.2023.03.006
|
2 |
Xionge Pi, Weilin Teng, Dibo Fei, Gang Zhao, Wei Liu. Effects of Live Combined Bacillus subtilis and Enterococcus faecium on Gut Microbiota Composition in C57BL/6 Mice and in Humans. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.821662
|
3 |
Zoe Martin, Georgia Spry, Jen Hoult, Isabella R. Maimone, Xueying Tang, Megan Crichton, Skye Marshall. What is the efficacy of dietary, nutraceutical, and probiotic interventions for the management of gastroesophageal reflux disease symptoms? A systematic literature review and meta-analysis. Clinical Nutrition ESPEN 2022; 52: 340 doi: 10.1016/j.clnesp.2022.09.015
|
4 |
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, Junichi Akiyama, Michio Hongo, Kenneth J. Vega. Potential proton pump inhibitor–related adverse effects. Annals of the New York Academy of Sciences 2020; 1481(1): 43 doi: 10.1111/nyas.14428
|
5 |
Wenjun Liu, Yong Xie, Yingmeng Li, Longjin Zheng, Qiuping Xiao, Xu Zhou, Qiong Li, Ni Yang, Kexuan Zuo, Tielong Xu, Nong-Hua Lu, Heping Zhang. Protocol of a randomized, double-blind, placebo-controlled study of the effect of probiotics on the gut microbiome of patients with gastro-oesophageal reflux disease treated with rabeprazole. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02320-y
|
6 |
Maria Rescigno. Microbiota in Reflux Esophagitis and Peptic Ulcer Disease. Surgical Infections 2023; 24(3): 245 doi: 10.1089/sur.2023.021
|
7 |
Jing Cheng, Arthur C. Ouwehand. Gastroesophageal Reflux Disease and Probiotics: A Systematic Review. Nutrients 2020; 12(1): 132 doi: 10.3390/nu12010132
|
8 |
Diego Cardoso BAIMA, Nayara Salgado CARVALHO, Ricardo Correa BARBUTI, Tomas NAVARRO-RODRIGUEZ. ASSESSMENT OF THE INTESTINAL MICROBIOTA IN ADULTS WITH EROSIVE ESOPHAGITIS. Arquivos de Gastroenterologia 2021; 58(2): 168 doi: 10.1590/s0004-2803.202100000-29
|
9 |
Laura Bozomitu, Ingrith Miron, Anca Adam Raileanu, Ancuta Lupu, Gabriela Paduraru, Florin Mihai Marcu, Ana Maria Laura Buga, Daniela Carmen Rusu, Felicia Dragan, Vasile Valeriu Lupu. The Gut Microbiome and Its Implication in the Mucosal Digestive Disorders. Biomedicines 2022; 10(12): 3117 doi: 10.3390/biomedicines10123117
|
10 |
Fan Yang, Xin-hui Xie, Xi Li, Hui-na Liao, Bing Zou. Analysis of Psychological and Gut Microbiome Characteristics in Patients With Non-erosive Reflux Disease. Frontiers in Psychiatry 2022; 12 doi: 10.3389/fpsyt.2021.741049
|
11 |
Lisanne M. M. Gommers, Joost G. J. Hoenderop, Jeroen H. F. de Baaij. Mechanisms of proton pump inhibitor‐induced hypomagnesemia. Acta Physiologica 2022; 235(4) doi: 10.1111/apha.13846
|
12 |
旭阳 刘. The Relationship between Methane and Small Intestine Bacterial Overgrowth. Advances in Clinical Medicine 2023; 13(02): 1940 doi: 10.12677/ACM.2023.132268
|
13 |
Diego Cabral Lacerda, Paulo César Trindade da Costa, Luciana Caroline Paulino do Nascimento, José Luiz de Brito Alves. Probiotics for Human Nutrition in Health and Disease. 2022; : 431 doi: 10.1016/B978-0-323-89908-6.00022-4
|
14 |
D’Souza Steve M, Cundra Lindsey B, Yoo Byung Soo, Parekh Parth J, Johnson David A. Microbiome and Gastroesophageal Disease: Pathogenesis and Implications for Therapy. Annals of Clinical Gastroenterology and Hepatology 2020; 4(1): 020 doi: 10.29328/journal.acgh.1001018
|
15 |
Rae McAtee, Sarah M. Schmid, M. Katherine Tolbert, Scott Hetzel, Jan S. Suchodolski, Jessica C. Pritchard. Effect of esomeprazole with and without a probiotic on fecal dysbiosis, intestinal inflammation, and fecal short‐chain fatty acid concentrations in healthy dogs. Journal of Veterinary Internal Medicine 2023; 37(6): 2109 doi: 10.1111/jvim.16886
|
16 |
I. G. Bakulin, M. Yu. Serkova. Medicinal-microbial interactions and ways of correcting iatrogenic intestinal dysbiosis. Experimental and Clinical Gastroenterology 2023; (11): 26 doi: 10.31146/1682-8658-ecg-207-11-26-35
|
17 |
Wenbo Xie, Lu An, Zhaoyang Liu, Xindi Wang, Xueqi Fu, Junfeng Ma. Therapeutic Effect of Polaprezinc on Reflux Esophagitis in the Rat Model. Digestive Diseases and Sciences 2023; 68(8): 3283 doi: 10.1007/s10620-023-07990-6
|
18 |
Sabina Fijan, Jessica A. ter Haar, László Varga. Advances in Probiotics. 2021; : 3 doi: 10.1016/B978-0-12-822909-5.00001-0
|
19 |
Kevin V. Houston, Alsiddig Elmahdi, Isaac Davis, Ana Vilela, Byung Soo Yoo, Steve M. D’Souza, David A. Johnson. Esophageal Disease and the Role of the Microbiome. 2023; : 177 doi: 10.1016/B978-0-323-95070-1.00005-9
|
20 |
Qing-Hua Sun, Hong-Yan Wang, Shi-Dong Sun, Xin Zhang, Han Zhang. Retraction note to: Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial. World Journal of Gastroenterology 2023; 29(1): 221-222 doi: 10.3748/wjg.v29.i1.221
|
21 |
Anindita Ghosh, Arti Muley, Archana S Ainapure, Aditi R Deshmane, Anu Mahajan. Exploring the Impact of Optimized Probiotic Supplementation Techniques on Diabetic Nephropathy: Mechanisms and Therapeutic Potential. Cureus 2024; doi: 10.7759/cureus.55149
|